CLINICAL ASPECTS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN ELDERLY PATIENTS WITH CARDIOVASCULAR PATHOLOGY

CLINICAL ASPECTS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN ELDERLY PATIENTS WITH CARDIOVASCULAR PATHOLOGY

Aim. To evaluate efficacy and safety of original ethylmethylhydroxypyridine succinate (Mexidol) in cardiological patients ≥75 year old.Material and methods. In the observational study, according to ethical standards of Khelsinki Declaration, with informed consent, 24 patients participated, age 7588...

Full description

Bibliographic Details
Main Author:	E. G. Martemianova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2018-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	mexidol heart failure frailty
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/803

Similar Items

Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups
by: E. A. Ushkalova, et al.
Published: (2022-10-01)

THE EFFECT OF SUBINHIBITORY CONCENTRATIONS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON BIOFILMS OF MICROORGANISMS
by: Vazhnichaya E. M., et al.
Published: (2022-03-01)

Cognitive impairments as a universal clinical syndrome in a therapist's practice
by: V N Shishkova
Published: (2014-11-01)

COMPARATIVE ANTICONVULSANT AND ANTIHYPOXIC EFFECTS OF ASTROKS AND MEXIDOL IN INJECTABLE FORM AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE SUBSTANCE
by: T. A. Voronina, et al.
Published: (2016-06-01)

Chemoreactome analysis of ethylmethylhydroxypyridine succinate
by: O. A. Gromova, et al.
Published: (2016-11-01)

The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients
by: Takuro Abe, et al.
Published: (2023-06-01)

Treatment of vertigo in elderly patients with chronic cerebrovascular disease
by: S. N. Duma
Published: (2018-04-01)

Effect of mexidol on lipid-phospholipid profile changes in elderly patients with stroke
by: Yu. V. Abramenko
Published: (2018-06-01)

Clinical Perspectives on Cardiac Rehabilitation After Heart Failure in Elderly Patients with Frailty: A Narrative Review
by: Tsukakoshi D, et al.
Published: (2022-10-01)

Promising effects of emoxypine and its succinate derivative in the management of various diseases-with insights on recent patent applications
by: Dhruv Sanjay Gupta, et al.
Published: (2022-01-01)

POSITIVE EXPERIENCE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USAGE IN CARDIOLOGICAL PATIENTS
by: R. G. Oganov
Published: (2017-10-01)

Possibilities of multimodal neuroprotection in patients with chronic cerebral ischemia on the background of arterial hypertension and atherosclerosis
by: I. A. Gribacheva, et al.
Published: (2023-05-01)

Effective tissue antiischemic therapy of etiologically various vascular diseases of the brain
by: A. L. Vertkin
Published: (2016-04-01)

The efficacy and safety of ethyl methyl hydroxypyridine succinate used as part of sequential therapy in patients with chronic cerebral ischemia
by: V. V. Burdakov, et al.
Published: (2020-02-01)

The role of frailty in selecting patients for heart transplantation
by: N. N. Koloskova, et al.
Published: (2022-07-01)

Interaction of erythrocyte membranes with derivatives of 3-oxypiridines
by: E. E. Kuznetsova, et al.
Published: (2017-09-01)

EXPERIMENTAL STUDY OF GASTROPROTECTIVE ACTIVITY OF TRANSDERMAL ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE
by: S. O. Losenkova, et al.
Published: (2015-09-01)

Sex differences in the impact of frailty in elderly outpatients with heart failure
by: Pablo Díez-Villanueva, et al.
Published: (2022-09-01)

Scoring the physical frailty phenotype of patients with heart failure
by: Masaaki Konishi
Published: (2022-02-01)

The relationship between frailty syndrome and self-care ability in the elderly with heart failure
by: Leila Zahed Nakhjiri, et al.
Published: (2021-01-01)

OXIDATIVE STRESS AND ITS PHARMACOLOGICAL CORRECTION by MEXIDOL IN TRAUMATIC BRAIN INJURY
by: N. V. Govorova
Published: (2016-02-01)

Changes in lipid peroxidation and antioxidant system parameters in the liver of rats using mexidol in experimental obesity and bronchial asthma
by: O.P. Mialiuk, et al.
Published: (2022-02-01)

Changes of biomechanical properties of the shoulder bone of white rate on the background of the deffects of the greater bone and the possibility of their pharmacological correction
by: Galina Lukyantseva
Published: (2017-06-01)

Prevalence and prognostic impact of cognitive frailty in elderly patients with heart failure: sub‐analysis of FRAGILE‐HF
by: Shuhei Yamamoto, et al.
Published: (2022-06-01)

EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE
by: T. N. Khaybullin, et al.
Published: (2015-12-01)

EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE
by: T. N. Khaybullin, et al.
Published: (2015-12-01)

EVIDENCE BASE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USE IN PATIENTS WITH STROKE AND ITS CONSEQUENCES
by: A. D. Ehrlikh, et al.
Published: (2015-09-01)

EVIDENCE BASE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USE IN PATIENTS WITH STROKE AND ITS CONSEQUENCES
by: A. D. Ehrlikh, et al.
Published: (2015-09-01)

Chemotranscriptome analysis of the ethylmethylhydroxypyridine succinate molecule in the context of postgenomic pharmacology
by: O. A. Gromova, et al.
Published: (2020-10-01)

Overlap of frailty and malnutrition as prognosticators in older patients with heart failure
by: Takuro Abe, et al.
Published: (2024-10-01)

Between a Rock and a Hard Place
by: Ariela R. Orkaby, MD, MPH, et al.
Published: (2024-10-01)

Assessment of frailty and related outcomes in older patients with heart failure: A cohort study
by: Georgios Tournas, et al.
Published: (2022-09-01)

Association of Diagnostic Coding‐Based Frailty and Outcomes in Patients With Heart Failure: A Report From the Veterans Affairs Health System
by: Shun Kohsaka, et al.
Published: (2020-12-01)

Effect of the combination of mexidol and diclofenac sodium on exudative inflammation in rats after ten-day preventive oral administration
by: E. A. Ivanova, et al.
Published: (2022-05-01)

Electron microscopic features of thyroid parafollicular cells in rats after a 60-day administration of Tartrazine and Mexidol ®
by: Luzin, Vladyslav I., et al.
Published: (2023-06-01)

Effect of the 60-day introduction of tartrazine and mexidol on the ultrastructure of the rat’s parathyroid gland chief cells
by: V.I. Luzin, et al.
Published: (2023-12-01)

The burden of frailty in heart failure: Prevalence, impacts on clinical outcomes and the role of heart failure medications
by: Hsi‐Yu Lai, et al.
Published: (2024-04-01)

Geriatric information analysis of the molecular properties of mexidole
by: O. A. Gromova, et al.
Published: (2017-12-01)

Investigation antiradical and antioxidative action dezapur in experements in vitro
by: V. A. Volkovoy, et al.
Published: (2016-06-01)

Investigation antiradical and antioxidative action dezapur in experements in vitro
by: V. A. Volkovoy, et al.
Published: (2016-06-01)